In this lecture from This is Why, Dr. Busti will explain how Long-Acting Beta Agonists (LABAs) work, where they fit in therapy for the management of asthma and COPD.
You’ll learn how to:
- Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation)
- Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS)
- Onset/duration differences and practical inhaler considerations
- Adverse effects & warnings: tachycardia, tremor, hypokalemia, paradoxical bronchospasm, and key safety concepts
- Therapeutic combos: ICS/LABA combination inhalers and where they fit (including common guideline concepts)
LABA drugs discussed for SEO/review:
- Salmeterol
- Formoterol
- Vilanterol
- Olodaterol
- Indacaterol
The goal = make medical education easy and clinically relevant.
Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/laba-long-acting-beta-agonists-asthma-copd-bronchodilators-pharmacology
Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources
If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
#LABA #LongActingBetaAgonist #Asthma #Bronchodilators #busti
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.
